Cooling a burning mouth: is TRPM8 the therapeutically relevant target of clonazepam in burning mouth disorder?
Neurobiology of Pain · 2026-07 · 20 · 100232
DOI: 10.1016/j.ynpai.2026.100232 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurobiology of Pain, 2026-07. Verfasst von Logan Elkin und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell Biology, Neurobiology, and Anatomy, Medical College of Wisconsin, Milwaukee, WI 53226, USA. Die Arbeit nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS, National Institutes of Health, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
Burning mouth disorder (BMD) is an extremely painful oral condition that occurs at the highest prevalence in post-menopausal women. Treatment options remain limited and remission rates poor, highlighting a need for identification of relevant molecular targets that can be prosecuted for effective therapeutics. One treatment that realizes benefit in patients with burning mouth disorder is clonazepam, a benzodiazepine known to work by augmenting currents through gamma aminobutyric acid A (GABAA) ion channels to inhibit neuronal firing. Here, we highlight an ancillary target for clonazepam as the transient receptor potential melastatin 8 (TRPM8) ion channel. In this commentary, evidence supporting the idea that TRPM8 acts as the therapeutically relevant local mediator of clonazepam action in BMD is summarized, with the goal of spurring new treatments for this debilitating and painful condition.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cell Biology, Neurobiology, and Anatomy, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
Förderung
- NIAID NIH HHS
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases
Zitieren
APA
Elkin, L., & Marchant, J. S. (2026). Cooling a burning mouth: is TRPM8 the therapeutically relevant target of clonazepam in burning mouth disorder?. Neurobiology of Pain, 20, 100232. https://doi.org/10.1016/j.ynpai.2026.100232
Vancouver
Elkin L, Marchant JS. Cooling a burning mouth: is TRPM8 the therapeutically relevant target of clonazepam in burning mouth disorder?. Neurobiology of Pain. 2026;20:100232. doi:10.1016/j.ynpai.2026.100232
BibTeX
@article{Elkin2026,
author = {Elkin, Logan and Marchant, Jonathan S},
title = {Cooling a burning mouth: is TRPM8 the therapeutically relevant target of clonazepam in burning mouth disorder?},
journal = {Neurobiology of Pain},
year = {2026},
volume = {20},
pages = {100232},
doi = {10.1016/j.ynpai.2026.100232}
}
EUVIMED